Rallybio Corporation Common Stock (NASDAQ: RLYB) last traded at $16.83, up 1.39% on the session. The quote above updates while this page is open; the figures below are drawn from Rallybio Corporation Common Stock’s own filings and are restated only when a new one is published.
Rallybio Corporation Common Stock trades on NASDAQ under the ticker RLYB. Its market capitalisation is $89.38 million.
Valuation measures for Rallybio Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $89.38M |
|---|---|
| Enterprise value | $93.7K |
| P/E ratio | 2.13 |
| Price / sales | 138.35 |
| Price / book | 0.95 |
| Beta | 0.86 |
Trailing-twelve-month figures tagged in Rallybio Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $646.0K |
|---|---|
| Net income (TTM) | $45.55M |
| EPS (TTM) | $7.90 |
| Operating margin | -4291.49% |
| Return on equity | 48.20% |
| Cash | $92.85M |
Range and volume for RLYB over the past 52 weeks.
| 52-week high | $17.57 |
|---|---|
| 52-week low | $3.67 |
| Volume | 6.7K |
| Average volume | 46.2K |
| Previous close | $16.60 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.